Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and Hong Kong. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine; generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
Frequently asked questions
What sector does Lansen Pharmaceutical Holdings Ltd (0503) operate in?
Lansen Pharmaceutical Holdings Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Lansen Pharmaceutical Holdings Ltd (0503) current stock price?
As of the latest data, Lansen Pharmaceutical Holdings Ltd stock price is HK$1.49, with a previous close of HK$1.50. Lansen Pharmaceutical Holdings Ltd lost -HK$0.01 in the last trading session, representing a -0.67% loss.
What is Lansen Pharmaceutical Holdings Ltd (0503) current market capitalization?
Lansen Pharmaceutical Holdings Ltd market cap is approximately 624.80 million.
Does Lansen Pharmaceutical Holdings Ltd (0503) pay dividends?
No. Lansen Pharmaceutical Holdings Ltd does not pay a dividend.
What is Lansen Pharmaceutical Holdings Ltd (0503) beta (volatility) score?
Lansen Pharmaceutical Holdings Ltd has a beta of 0.917, meaning its volatility is roughly in line with the market.
